SPP1 and ischemic cardiomyopathy: In conclusion, osteopontin seems to modulate expression of contractile elements, antioxidative enzymes, inflammatory response, and early development of interstitial fibrosis in order to prevent irreversible cardiomyocyte loss in murine ischemic cardiomyopathy.